tm
Seeing Is Believing
tm
Seeing Is Believing
Aerovate Therapeutics's activity chart (see below) currently has 16 price targets and 16 ratings on display.
Analysts average stock forecasts to be materialized ratio is 42.59% with an average time for these price targets to be met of 56.89 days.
Most recent stock forecast was given by VAMIL DIVAN from GUGGENHEIM on 18-Jun-2024. First documented stock forecast 26-Jul-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$36
2 years 4 months 2 days ago
(18-Jun-2024)
0/1 (0%)
$13.53 (60.21%)
Buy Since 01-Apr-2024
$70
$-21.4 (-23.41%)
$1225
2 years 4 months 3 days ago
(18-Jun-2024)
1/2 (50%)
$21.91 (45.56%)
100
Buy Since 26-Jul-2021
$27
$-64.4 (-70.46%)
$1050
2 years 4 months 3 days ago
(18-Jun-2024)
0/2 (0%)
$-21.09 (-43.86%)
$41
2 years 4 months 3 days ago
(17-Jun-2024)
0/3 (0%)
$21.09 (105.93%)
Hold Since 17-Jun-2024
$2275
$2183.6 (2389.06%)
$2275
2 years 4 months 4 days ago
(17-Jun-2024)
1/3 (33.33%)
$2218.73 (3943.01%)
49
What is AVTE (Aerovate Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on AVTE (Aerovate Therapeutics)?
Which analyst has the most public recommendations on AVTE (Aerovate Therapeutics)?
Which analyst is the currently most bullish on AVTE (Aerovate Therapeutics)?
Which analyst is the currently most reserved on AVTE (Aerovate Therapeutics)?
